Novavax begins phase two COVID-19 vaccine trail in SA

The global race for a COVID-19 vaccine has been won by Russia who announced that it has produced the first batch of its vaccine this week. However in South Africa, the motto of slow and steady wins the race is in full effect as American vaccine group Novavax will begin a phase two clinical trial in the country this week. Joining CNBC Africa to unpack more on the progress of South Africa’s COVID-19 vaccine trial is Dr Clare Cutland, Scientific Coordinator for the African Leadership in Vaccinology Expertise Consortium.

Partner Content

Disruptive digital solutions is rewiring the DNA of Banking

By Kennedy Mubita, Africa Head, SC Ventures. Imagine a bank whose customers can tap on a wearable device to...

The future of banking; digitization and collaboration as growth accelerants

By Kariuki Ngari, CEO & Managing Director, Standard Chartered, Kenya & East Africa COVID-19 has upended the social and...

Star Quality Speaker Line-Up at Africa Tech Festival 2020

Acknowledged as the world’s largest Africa-focused digital infrastructure and emerging tech event, the Africa Tech Festival has always attracted a stellar line-up of critical thinkers, analysts, futurists, keynote and inspirational speakers. 2020 will more than deliver on that reputation, with a stimulating array of visionary industry presenters, raconteurs and even some sporting greats.


Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox